Pharma Outsourcing 2019

The international annual partnering meeting is targeted at R&D and CMC professionals, service providers and Investment Managers, and provides an opportunity to meet, network and discuss best practices related to outsourcing in drug development.

Organized for the 5th time, the event will cover all stages from preclinical research to late clinical phases, preclinical and clinical bioanalysis as well as contract manufacturing and regulatory issues. The day will feature 30 exhibitors, and is expected to attract around 160 delegates. Pharma Outsourcing will cover contract research and manufacturing in both small molecule and biological APIs, and the event will be covered by the media.

In 2017, the number of patents registered in Sweden reached an all-time high, and we have seen continuing investment. But are the life sciences in flux /in constant change/, and are there global opportunities for a global industry? We want to investigate how you achieve outsourcing drug development, and the journey of getting a drug to market.

Virtual companies have succeeded in their preclinical work, they are now recruiting patients for clinical trials, and hope to make money from products within a couple of years in order to reward shareholders.

Dan Millard from PCI will be exhibiting at Pharma Outsourcing 2019 and available to discuss your pharmaceutical outsourcing needs

For more information or to register for this event, please see the event website